Recruiting studies: Specific Antibody Deficiency

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Phase N/A · 52 location(s) · Ensoma · NCT06605378 Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
Phase 2 · 17 location(s) · ANRS, Emerging Infectious Diseases · NCT05300035 Frequency of SPAD in Adult Patients
Phase N/A · 1 location(s) · University Hospital, Lille · NCT05664035 A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
Phase 2 · 12 location(s) · Imperial College London · NCT04319367 EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Eisbach Bio GmbH · NCT06525298

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.